• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胆汁酸测定在妊娠期肝内胆汁淤积症管理中的作用]

[The role of bile acid measurement in the management of intrahepatic cholestasis of pregnancy].

作者信息

Deli Tamás, Tóth Judit, Csépes-Ruzicska Lea, Török Olga, Krasznai Zoárd Tibor, Mosolygó-Lukács Ágnes, Kappelmayer János, Lampé Rudolf

机构信息

1 Debreceni Egyetem, Általános Orvostudományi Kar, Szülészeti és Nőgyógyászati Intézet Debrecen, Nagyerdei krt. 98., 4032 Magyarország.

2 Debreceni Egyetem, Általános Orvostudományi Kar, Laboratóriumi Medicina Intézet Debrecen Magyarország.

出版信息

Orv Hetil. 2022 May 15;163(20):797-805. doi: 10.1556/650.2022.32474.

DOI:10.1556/650.2022.32474
PMID:35569059
Abstract

Introduction: Intrahepatic cholestasis of pregnancy complicates 1% of pregnancies. It increases the risk of severe fetal complications significantly, including preterm delivery and stillbirth. Objective: To summarize our experience with serum total bile acid level measurement that has recently become available for clinical routine in Hungary, and to present the way of gestational cholestasis care at our university. Patients and method: In a retrospective case series, we analyse the data of 12 patients suffering from severe cholestasis of pregnancy treated between September 2020 and September 2021 at the Department of Obstetrics and Gynecology, University of Debrecen. We also determine the statistical correlation between bile acid, transaminase and bilirubin levels in severe cholestasis. Results: 1258 serum samples of 758 patients were measured. 5 of them (0.7% of all cases, 6.4% of cholestasis cases) had severe (total bile acid 40-99 mu mol/L), 7 (0.9% of all cases and 9.0% of cholestasis cases) had very severe (total bile acid >= 100 mu mol/L) disease. The average age of the 12 cases was 30.6 (21-43) years, 7 of them were primigravid. 5 of the patients had a predisposing disease in their history. 6/12 patients received ursodeoxycholic acid treatment, resulting in significant decrease in the bile acid concentrations. Bile acid and GOT (R-2 = 0,14) and bile acid and GPT (R-2 = 0,17) correlations were found to be week in severe cholestasis (n = 45). Postpartum bile acid levels showed rapid improvement. So far, 11 of the patients have delivered and 13 neonates were born, 2/12 were multiple pregnancies. Average gestational age at delivery was 37 (33-40) weeks. 3/11 (27%) were preterm deliveries. 7/8 (88%) of term deliveries were induced. Elective cesarean delivery was not indicated in any of the cases, and in only 2/11 (18%) of the cases did emergency cesarean sections become necessary during labour. No stillbirth occurred. Conclusion: Serum total bile acid measurement is an effective tool in the diagnosis and follow-up of intrahepatic cholestasis of pregnancy, and is inevitable for the protocoll-based obstetrical management of patients. We also present the local protocol of our Department for the management of obstetrical cholestasis.

摘要

引言

妊娠期肝内胆汁淤积症在1%的妊娠中会出现并发症。它显著增加了严重胎儿并发症的风险,包括早产和死产。目的:总结我们在匈牙利最近已可用于临床常规的血清总胆汁酸水平测量方面的经验,并介绍我校妊娠期胆汁淤积症的护理方法。患者与方法:在一项回顾性病例系列研究中,我们分析了2020年9月至2021年9月在德布勒森大学妇产科接受治疗的12例重度妊娠期胆汁淤积症患者的数据。我们还确定了重度胆汁淤积症中胆汁酸、转氨酶和胆红素水平之间的统计相关性。结果:对758例患者的1258份血清样本进行了测量。其中5例(占所有病例的0.7%,胆汁淤积症病例的6.4%)患有重度(总胆汁酸40 - 99 μmol/L),7例(占所有病例的0.9%,胆汁淤积症病例的9.0%)患有极重度(总胆汁酸≥100 μmol/L)疾病。12例患者的平均年龄为30.6(21 - 43)岁,其中7例为初产妇。5例患者既往有易感疾病史。12例患者中有6例接受了熊去氧胆酸治疗,导致胆汁酸浓度显著降低。在重度胆汁淤积症(n = 45)中发现胆汁酸与谷草转氨酶(R² = 0.14)以及胆汁酸与谷丙转氨酶(R² = 0.17)的相关性较弱。产后胆汁酸水平迅速改善。到目前为止,11例患者已分娩,共出生13例新生儿,12例中有2例为多胎妊娠。分娩时的平均孕周为37(33 - 40)周。3/11(27%)为早产。8例足月分娩中有7例(88%)为引产。所有病例均未进行择期剖宫产,仅11例中有2例(18%)在分娩期间需要进行急诊剖宫产。未发生死产。结论:血清总胆汁酸测量是妊娠期肝内胆汁淤积症诊断和随访的有效工具,对于基于方案的患者产科管理是必不可少的。我们还介绍了我们科室妊娠期胆汁淤积症管理的本地方案。

相似文献

1
[The role of bile acid measurement in the management of intrahepatic cholestasis of pregnancy].[胆汁酸测定在妊娠期肝内胆汁淤积症管理中的作用]
Orv Hetil. 2022 May 15;163(20):797-805. doi: 10.1556/650.2022.32474.
2
Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.妊娠肝内胆汁淤积症胎儿心功能障碍与血清胆汁酸浓度升高有关。
J Hepatol. 2021 May;74(5):1087-1096. doi: 10.1016/j.jhep.2020.11.038. Epub 2020 Dec 1.
3
Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011.母胎医学会咨询系列第 53 号:妊娠肝内胆汁淤积症:取代 2011 年 4 月的咨询 13 号。
Am J Obstet Gynecol. 2021 Feb;224(2):B2-B9. doi: 10.1016/j.ajog.2020.11.002. Epub 2020 Nov 13.
4
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.妊娠肝内胆汁淤积症不良围产结局与生化标志物的关联:汇总和个体患者数据荟萃分析结果。
Lancet. 2019 Mar 2;393(10174):899-909. doi: 10.1016/S0140-6736(18)31877-4. Epub 2019 Feb 14.
5
The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.血清胆汁酸水平分析及熊去氧胆酸治疗在妊娠期肝内胆汁淤积症中的重要性:来自中欧的病例系列
Arch Dermatol. 2007 Jun;143(6):757-62. doi: 10.1001/archderm.143.6.757.
6
[Intrahepatic cholestasis of pregnancy: French College of Obstetricians and Gynecologists guidelines for clinical practice].[妊娠期肝内胆汁淤积症:法国妇产科医师学会临床实践指南]
Gynecol Obstet Fertil Senol. 2023 Nov-Dec;51(11-12):493-510. doi: 10.1016/j.gofs.2023.09.004. Epub 2023 Oct 6.
7
Beyond stillbirth: association of intrahepatic cholestasis of pregnancy severity and adverse outcomes.超越死胎:妊娠肝内胆汁淤积症严重程度与不良结局的关系。
Am J Obstet Gynecol. 2022 Sep;227(3):517.e1-517.e7. doi: 10.1016/j.ajog.2022.06.013. Epub 2022 Aug 18.
8
Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.妊娠肝内胆汁淤积症不良新生儿结局的预测因素
Am J Obstet Gynecol. 2015 Oct;213(4):570.e1-8. doi: 10.1016/j.ajog.2015.06.021. Epub 2015 Jun 10.
9
Obstetric cholestasis: outcome with active management.产科胆汁淤积症:积极管理的结局
Eur J Obstet Gynecol Reprod Biol. 2002 Jan 10;100(2):167-70. doi: 10.1016/s0301-2115(01)00463-8.
10
Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.熊去氧胆酸与安慰剂治疗妊娠肝内胆汁淤积症妇女(PITCHES):一项随机对照试验。
Lancet. 2019 Sep 7;394(10201):849-860. doi: 10.1016/S0140-6736(19)31270-X. Epub 2019 Aug 1.

引用本文的文献

1
Yinchenhao Decoction Protects Against Intrahepatic Cholestasis During Pregnancy Through the miR-370-3p/TM9SF4/KIT Axis.茵陈蒿汤通过miR-370-3p/TM9SF4/KIT轴预防妊娠期肝内胆汁淤积症。
Biomed Res Int. 2025 Jul 26;2025:3000226. doi: 10.1155/bmri/3000226. eCollection 2025.
2
Global and regional incidence of intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis.妊娠期肝内胆汁淤积症的全球及区域发病率:一项系统评价与荟萃分析
BMC Med. 2025 Feb 28;23(1):129. doi: 10.1186/s12916-025-03935-0.
3
Thyroid-stimulating hormone and total bile acids can predict adverse pregnancy outcome among patients with gestational hypertension.
促甲状腺激素和总胆汁酸可预测妊娠期高血压患者的不良妊娠结局。
Am J Transl Res. 2024 Apr 15;16(4):1199-1208. doi: 10.62347/POGR1624. eCollection 2024.